IAC Inc. Reports Reduced Losses in Q3
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 03 2025
0mins
Source: NASDAQ.COM
Quarterly Loss: IAC Inc. reported a loss of $21.9 million for the third quarter, translating to a loss of $0.27 per share, an improvement from a loss of $243.7 million or $2.93 per share in the same quarter last year.
Revenue Decline: The company's revenue decreased by 8.1%, falling to $589.8 million from $642.0 million compared to the previous year.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IAC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IAC
Wall Street analysts forecast IAC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IAC is 48.11 USD with a low forecast of 39.00 USD and a high forecast of 60.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 37.630
Low
39.00
Averages
48.11
High
60.00
Current: 37.630
Low
39.00
Averages
48.11
High
60.00
About IAC
IAC Inc. is engaged in building companies. The Company's segments include Dotdash Meredith, Care.com, Search, and Emerging & Other. Its Dotdash Meredith segment consists of its digital and print businesses. Through its digital businesses, it provides original and engaging digital content in a variety of formats, including articles, illustrations, videos, and images. Its print business is a magazine publisher, which has published over 18 magazines, as well as 370 special interest publications. Its Search segment consists of Ask Media Group, a collection of Websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations and direct-to-consumer downloadable desktop applications. Its Care.com primarily provides online consumer matching and consumer payment solutions for families searching for care, among others. Its Emerging & Other segment includes Vivian Health, The Daily Beast and IAC Films.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
IAC Stock 52-Week Range Analysis
- Price Fluctuation Analysis: IAC's 52-week low is $29.56, while the high is $50.49, with the last trade at $36.07, indicating significant price volatility within this range and reflecting market caution regarding its future performance.
- Technical Indicator Focus: IAC's stock has fallen below its 200-day moving average, suggesting potential further downside pressure in the short term, prompting investors to closely monitor subsequent market developments to assess investment risks.
- Market Sentiment Assessment: The current stock price is approximately 28.5% lower than the 52-week high, indicating a decline in market confidence in IAC, which could impact its future financing and expansion plans.
- Investor Strategy Adjustment: Given the volatility in IAC's stock price, investors may need to reassess their portfolios, considering whether to maintain or adjust their positions in response to market changes.
Continue Reading
Vivian Health Appoints New CEO to Drive AI Innovation
- Executive Changes: Vivian Health announced the appointment of Bill Kong as the new CEO, succeeding co-founder Parth Bhakta, who will transition to executive chairman, ensuring strategic alignment during AI-driven growth.
- Strategic Focus: Kong will lead the company's future strategy, emphasizing the development of its industry-leading talent marketplace, accelerating product innovation, and scaling through AI advancements to enhance market competitiveness.
- Expanded Financial Leadership: CFO Adam Greenberg will also take on the role of president & CFO, overseeing financial strategy, business operations, and corporate development, further integrating resources to support growth objectives.
- Immediate Implementation: All executive changes are effective immediately, marking Vivian Health's entry into a new phase of AI-driven development, which is expected to create new growth opportunities for the company.
Continue Reading